Lexicon Pharmaceuticals - Stock Price History | LXRX

Historical daily share price chart and data for Lexicon Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Lexicon Pharmaceuticals as of October 27, 2021 is 5.13.
  • The all-time high Lexicon Pharmaceuticals stock closing price was 329.81 on July 21, 2000.
  • The Lexicon Pharmaceuticals 52-week high stock price is 9.65, which is 88.1% above the current share price.
  • The Lexicon Pharmaceuticals 52-week low stock price is 1.03, which is 79.9% below the current share price.
  • The average Lexicon Pharmaceuticals stock price for the last 52 weeks is 4.72.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Lexicon Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.1500 4.0900 4.2800 1.0500 3.4200 -17.59%
2019 4.7374 6.9100 7.9400 1.2000 4.1500 -37.50%
2018 9.7648 10.1200 13.6900 6.1500 6.6400 -32.79%
2017 13.8660 14.2000 17.8800 8.7650 9.8800 -28.56%
2016 14.0806 13.1500 19.3000 8.0200 13.8300 3.91%
2015 9.3843 6.4598 15.7400 6.1938 13.3100 109.03%
2014 10.5342 12.5262 14.0658 5.9482 6.3674 -49.42%
2013 15.7359 16.6550 20.3639 12.1064 12.5892 -18.60%
2012 13.6112 8.7474 22.2533 8.1176 15.4654 71.32%
2011 10.4549 10.4969 15.4094 5.9244 9.0273 -10.42%
2010 10.8610 12.1064 15.7453 8.3975 10.0770 -15.29%
2009 9.7980 10.0770 18.4045 5.9482 11.8964 21.43%
2008 13.3952 21.3436 21.3436 6.3681 9.7971 -53.80%
2007 24.1332 25.8223 30.6508 19.8740 21.2036 -16.07%
2006 29.7896 26.6620 40.3779 24.1428 25.2624 -1.10%
2005 34.3161 51.7845 52.1344 23.6529 25.5423 -52.93%
2004 48.0191 42.3373 56.6830 36.8789 54.2687 31.66%
2003 36.4105 36.0392 50.9447 22.1134 41.2176 24.52%
2002 44.7806 78.2365 84.2547 23.4430 33.1001 -59.01%
2001 69.0564 97.9706 104.9685 39.8041 80.7558 -30.61%
2000 159.2795 131.2106 329.8111 63.8558 116.3751 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.754B $0.024B
Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomictechnologies to accelerate large-scale analysis of mammalian gene function for drug discovery.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86